KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Change in Cash (2016 - 2025)

Historic Change in Cash for Globus Medical (GMED) over the last 15 years, with Q3 2025 value amounting to $142.3 million.

  • Globus Medical's Change in Cash fell 3297.46% to $142.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$251.0 million, marking a year-over-year decrease of 17314.58%. This contributed to the annual value of $317.1 million for FY2024, which is 10.1% up from last year.
  • Globus Medical's Change in Cash amounted to $142.3 million in Q3 2025, which was down 3297.46% from -$231.8 million recorded in Q2 2025.
  • Over the past 5 years, Globus Medical's Change in Cash peaked at $212.3 million during Q3 2024, and registered a low of -$323.2 million during Q1 2025.
  • Over the past 5 years, Globus Medical's median Change in Cash value was $36.7 million (recorded in 2022), while the average stood at $7.0 million.
  • The largest annual percentage gain for Globus Medical's Change in Cash in the last 5 years was 716523.57% (2021), contrasted with its biggest fall of 140586.08% (2021).
  • Globus Medical's Change in Cash (Quarter) stood at -$168.8 million in 2021, then surged by 109.62% to $16.2 million in 2022, then soared by 1055.4% to $187.7 million in 2023, then fell by 13.85% to $161.7 million in 2024, then decreased by 11.97% to $142.3 million in 2025.
  • Its last three reported values are $142.3 million in Q3 2025, -$231.8 million for Q2 2025, and -$323.2 million during Q1 2025.